Investor directory

Isto Technologies

ISTO Technologies, Inc., an orthobiologics company, develops biologic products to regenerate and restore function to damaged cartilage and bone. It offers InQu, a resorbable bone graft extender and substitute; NuQu, a cell-based injectable therapy for disc regeneration; and DeNovo ET, an engineered cartilage implant for the repair and regeneration of knee cartilage. The company provides its products through distributors. ISTO Technologies, Inc. was founded in 1997 and is based in St. Louis, Missouri.
http://www.istotech.com
https://crunchbase.com/organization/isto-technologies

Alafi, Christopher D.

Director

Thomas Melzer

Director

1 past transactions

Arteriocyte

Acquisition in 2016
Arteriocyte Medical Systems, Inc. is a leading medical device company dedicated to helping patients heal faster by developing innovative solutions to improve the outcomes of surgical procedures based on cell and tissue based therapies. The Company’s lead product is the Magellan® Autologous Platelet Separator. The Magellan® System provides surgeons the ability to fractionate peripheral blood and/or aspirated bone marrow from a patient, for that patient, at bedside in approximately 15 minutes using a fully automated closed loop separation process. The Magellan® device yields a 3-10cc injectable unit of platelet and stem cell enriched plasma for the surgeon’s use in his or her procedure.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.